Teyiyao Pharmaceutical's 2025 Net Profit Grows 298.5% Year-over-Year; Proposes Distribution of 1.5 Yuan per 10 Shares

2026-03-23 18:22:36

On March 23, Teyi Pharmaceutical (002728.SZ) released its annual report, projecting a revenue of 925 million yuan in 2025, a year-over-year increase of 34.42% (adjusted); net profit attributable to shareholders is 81.6716 million yuan, a rise of 298.5% (adjusted). The company plans to distribute a cash dividend of 1.5 yuan (tax included) for every 10 shares to all shareholders.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes